Project HEARTS-Hop
Project HEARTS-Hop
High-Energy Accelerators for Radiation Testing and Shielding
Keywords: spacecraft, particle physics, microelectronics, radiation chemistry, ITER, FAIR, innovation
Brief project summary
Enhancing Europe’s competitiveness in space exploration and applications calls for more than the development of devices and systems. Testing these to gauge their performance in space is a challenging yet critical factor for success. The EU-funded HEARTS project plans to support the space community in this task, by providing access to its high-energy heavy-ion accelerator that can mimic the effects of galactic cosmic rays (GCRs). GCRs are composed of very-high-energy particles travelling at nearly the speed of light. They originate outside the solar system and are a dominant source of radiation that current and future spacecraft must withstand. The HEARTS team plans to help space scientists ensure their high-tech electronics can, in fact, do just that.
Objective
The main purpose of the HEARTS proposal is to provide high-energy (>100 MeV/n) heavy ion accelerator access to space users, in order to mimic the effects of Galactic Cosmic Rays (GCR) at ground level, and thus fulfilling the needs of microelectronics qualification and shielding & radiobiology experiments. These ions will successfully mimic the effects of heavy ions present in the GCR spectrum, and will also ensures penetration levels large enough to enable electronics testing in air, without the need of electronics device preparation (e.g. de-lidding, thinning) and at board and box level. High penetration ion irradiation is essential in order to facilitate the exploitation of high-end microelectronics technology in space, for e.g. onboard artificial intelligence or Big Data processing applications.
To this end, the HEARTS proposal features CERN and GSI as accelerator infrastructure partners, who also gather a vast experience and knowledge in radiation effects on electronics, and shielding & radiobiology, respectively.
Moreover, HEARTS features also the University of Padova as academic partner, and Thales Alenia Space and Airbus Defence and Space as industrial participants, all of which have ample experience in the radiation effects domain, and a strong interest in VHE ion testing. The academic and industrial partners will define the requirements, both technical and procedural, for VHE ion user facilities. Such requirements will serve as input to CERN and GSI and will be implemented as upgrade which, once completed, will be scrutinized and validated by the industrial and academic partners, through “real case” experimental campaigns that will in turn serve as input for the development of VHE ion testing recommendations and guidelines.
Therefore, in final instance, HEARTS ambitions to create a high quality and sustainable VHE ion irradiation capacity in Europe, accessible to and tailored for space users and applications.
Cosylab will contribute to HEARTS by providing its expertise and experience in the field of control system protocols and user interface tools. Cosylab has a track record of working with international scientific institutes, research and fusion energy organisations, medical device manufacturers and other organisations and entities.
Miha Vitorovič, Cosylab Project Manager, said:
“Our engineers at Cosylab are truly excited to collaborate on the HEARTS project, which will enable the two main high-energy ion accelerator infrastructures in Europe to work as a unison solution for research and industrial access in the fields of radiation effects in shielding, radiobiology and electronics. It will be an excellent opportunity for us to combine our expertise from both the scientific accelerator and space domain and work on single-tool solutions for user-managing beam parameters and user-tracking of the experiment lifecycle across the facilities.”
Project website: Hearts project
HEARTS is a project funded by the European Union under GA No 101082402, through the Horizon Europe- Digital, Industry and Space Programme.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.